Literature DB >> 22588054

Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.

Jin Chen1.   

Abstract

In recent years, a growing body of evidence has indicated that signaling molecules previously implicated in axon guidance are important regulators of multistep tumorigenesis and progression. Eph receptors and ephrins belong to this special class of molecules that play important roles in both axon guidance and cancer. Tremendous progress has been made in the past few years in both understanding the role of Eph receptors and ephrins in cancer and designing therapeutic strategies for cancer therapy. This review will focus on new advances in elucidating the contribution of Eph/ephrin molecules to key processes in tumor initiation and metastatic progression, including cancer cell proliferation, invasion and metastasis, and tumor angiogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588054      PMCID: PMC3626259          DOI: 10.1016/B978-0-12-386503-8.00001-6

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  96 in total

1.  Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Authors:  Laura D Wood; Eric S Calhoun; Natalie Silliman; Janine Ptak; Steve Szabo; Steve M Powell; Gregory J Riggins; Tian-Li Wang; Hai Yan; Adi Gazdar; Scott E Kern; Len Pennacchio; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

2.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

3.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Authors:  S Ram Kumar; Jasbir Singh; Guangbin Xia; Valery Krasnoperov; Loubna Hassanieh; Eric J Ley; Jeffrey Scehnet; Neil G Kumar; Debra Hawes; Michael F Press; Fred A Weaver; Parkash S Gill
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

4.  A critical role for the EphA3 receptor tyrosine kinase in heart development.

Authors:  Lesley J Stephen; Amy L Fawkes; Adam Verhoeve; Greg Lemke; Arthur Brown
Journal:  Dev Biol       Date:  2006-08-30       Impact factor: 3.582

5.  Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.

Authors:  Sonja G Hunter; Guanglei Zhuang; Dana Brantley-Sieders; Wojciech Swat; Christopher W Cowan; Jin Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

6.  The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.

Authors:  Nicole K Noren; Gabriele Foos; Craig A Hauser; Elena B Pasquale
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

7.  Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.

Authors:  Hong Guo; Hui Miao; Lizabeth Gerber; Jarnail Singh; Mitchell F Denning; Anita C Gilliam; Bingcheng Wang
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

8.  Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer.

Authors:  Marcia V Fournier; Katherine J Martin; Paraic A Kenny; Kris Xhaja; Irene Bosch; Paul Yaswen; Mina J Bissell
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

9.  Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.

Authors:  Charles N Landen; Chunhua Lu; Liz Y Han; Karen T Coffman; Elizabeth Bruckheimer; Jyotsnabaran Halder; Lingegowda S Mangala; William M Merritt; Yvonne G Lin; Changhou Gao; Rosemarie Schmandt; Aparna A Kamat; Yang Li; Premal Thaker; David M Gershenson; Nila U Parikh; Gary E Gallick; Michael S Kinch; Anil K Sood
Journal:  J Natl Cancer Inst       Date:  2006-11-01       Impact factor: 13.506

10.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

View more
  25 in total

1.  JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.

Authors:  Wenqiang Song; Yufang Ma; Jialiang Wang; Dana Brantley-Sieders; Jin Chen
Journal:  Cancer Res       Date:  2014-03-07       Impact factor: 12.701

2.  The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.

Authors:  Deanna N Edwards; Verra M Ngwa; Shan Wang; Eileen Shiuan; Dana M Brantley-Sieders; Laura C Kim; Albert B Reynolds; Jin Chen
Journal:  Sci Signal       Date:  2017-12-05       Impact factor: 8.192

Review 3.  Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.

Authors:  Dimitar B Nikolov; Kai Xu; Juha P Himanen
Journal:  Biochim Biophys Acta       Date:  2013-04-26

4.  Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.

Authors:  Katherine R Amato; Shan Wang; Andrew K Hastings; Victoria M Youngblood; Pranav R Santapuram; Haiying Chen; Justin M Cates; Daniel C Colvin; Fei Ye; Dana M Brantley-Sieders; Rebecca S Cook; Li Tan; Nathanael S Gray; Jin Chen
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

Review 5.  Eph receptor tyrosine kinases in cancer stem cells.

Authors:  Jin Chen; Wenqiang Song; Katherine Amato
Journal:  Cytokine Growth Factor Rev       Date:  2014-05-17       Impact factor: 7.638

6.  Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.

Authors:  Alexander S Hahn; Ronald C Desrosiers
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

Review 7.  Milk secretion: The role of SNARE proteins.

Authors:  Sandrine Truchet; Sophie Chat; Michèle Ollivier-Bousquet
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-11-22       Impact factor: 2.673

8.  Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.

Authors:  Sarah K Denny; Dian Yang; Chen-Hua Chuang; Jennifer J Brady; Jing Shan Lim; Barbara M Grüner; Shin-Heng Chiou; Alicia N Schep; Jessika Baral; Cécile Hamard; Martine Antoine; Marie Wislez; Christina S Kong; Andrew J Connolly; Kwon-Sik Park; Julien Sage; William J Greenleaf; Monte M Winslow
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

9.  EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination.

Authors:  L Gómez-Maldonado; M Tiana; O Roche; A Prado-Cabrero; L Jensen; A Fernandez-Barral; I Guijarro-Muñoz; E Favaro; G Moreno-Bueno; L Sanz; J Aragones; A Harris; O Volpert; B Jimenez; L del Peso
Journal:  Oncogene       Date:  2014-07-14       Impact factor: 9.867

10.  VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity.

Authors:  Meghana Rao; Wenqiang Song; Aixiang Jiang; Yu Shyr; Sima Lev; David Greenstein; Dana Brantley-Sieders; Jin Chen
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.